The Australian Securities Exchange must make "foundational changes" to its governance, culture and risk management after last ...

Shares are set to open up; Synlait sells North Island assets to Abbott; $A off three-week lows; RBA to hold rates steady; ...

A third ASX growth share to hold onto until the 2030s could be Pro Medicus. It is one of Australia's leading healthcare ...

In morning trade, the ASX defence stock is up 7% to a record high of $8.93. Investors have been bidding the defence and space ...

Wall Street snapped a 3-day losing streak with solid gains on Friday. Follow today's events and insights from our business ...

Shares subdued; Elanor independent board fund rejects Lederer bid; Vulcan inks $179m power plant deal; Gold Road delisted ...

There’s a forgotten market giant riding a powerful tailwind from a deeply undervalued starting position. Smart money is pouring in and the gains could be life changing, writes ASX Trader. Most ...

With no signs of an imminent outbreak of global peace, defence-related stocks have surged in value as investors catch khaki ...

The ASX managed to tip into the green today, rising marginally on strength in resources and banking stocks as Trump threatens ...

Australian shares are heading into Week 40 in the green, according to ASX 200 futures, though whether that +0.4% gain holds ...

Trump smacks healthcare with tariffs, silver rockets past US$45, and Vulcan pops on a $179m German deal. It's all happening ...

Analysts think these shares could help income investors beat falling interest rates. The post 3 super ASX dividend shares to ...